Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Semi-annual Business Results
December 1, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
December 1, 2003
- Mochida: Profits Decline Despite Slight Growth in Pharma Sales
December 1, 2003
- DIAGNOSTIC NEWS IN BRIEF
December 1, 2003
- Fuso: Profits Marked for 1st Time in 3 Years
December 1, 2003
- SEMI-ANNUAL BUSINES RESULTS
December 1, 2003
- Teijin: Sales Up, but Operating Profits Hit by R&D Costs
December 1, 2003
- Hearings on Late-night, Early-morning Drug Sales Held
December 1, 2003
- Sawai: Favorable GE Market Drives Strong Growth in Sales, Profits
December 1, 2003
- OTC NEWS IN BRIEF
December 1, 2003
- Kuraya Sanseido: Sales, Net Profits Up Slightly
December 1, 2003
- PRESS SEMINAR
December 1, 2003
- Kissei: Sales Increase 1.3%, Profits Up 281.2%
December 1, 2003
- WORLD NEWS IN BRIEF
December 1, 2003
- Nippon Shinyaku: Sales Up Slightly, Profits Hit by Higher Costs
December 1, 2003
- Rewards for Innovativeness in New Drugs to Be Needed: Mr Ager of EFPIA
December 1, 2003
- Kaken: Ordinary Profits Down, but R&D Tax Credit Boosts Net Profits
December 1, 2003
- ICH-6 in Osaka Focuses on New Horizons and Future Challenges (1)
December 1, 2003
- Meiji Seika: Drug Division Sales Up 6.5% to \49.5 Bil.
December 1, 2003
- Chuikyo Discusses NPA Recommendation, Consumer Prices
December 1, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…